Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

The purpose of this protocol is to compare neoadjuvant chemoradiation plus consolidation chemotherapy before surgical resection with the standard neoadjuvant chemoradiation followed by surgical resection and adjuvant chemotherapy in patients with rectal cancer.

Trial Details

NCT ID
NCT05496491
Phase
NA
Sponsor
Larissa University Hospital
Status
RECRUITING
Cancer Type
Rectal Cancer Colorectal Cancer
Interventions
  • Neoadjuvant Chemoradiotherapy
  • Adjuvant Chemotherapy
  • Consolidation Chemotherapy
Locations (sample)
  • Larissa, Greece|39.62847,22.42112

Key Eligibility Criteria

  • Histologically confirmed rectal adenocarcinoma
  • cT3, cT4, threatened CRM / MRF, EMVI (+), ≥N1
  • Multidisciplinary tumor board decision for neoadjuvant treatment
  • Tumor distance from the anal verge \<15 cm based on endoscopy or magnetic resonance imaging

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Rectal Cancer Colorectal Cancer Trials on Trialify →